Analysis of clinical variables associated with progression free survival in NSCLC EGFR-mutant patients.
收藏数据链接：
官方服务：
资源简介：
‡reference group was exon 21. EGFR: epidermal growth factor receptor, TKI: tyrosine kinase inhibitor, ECOG PS: eastern cooperation oncology group performance status, HR: hazard ratio, CI: confidence interval.
创建时间：
2015-12-02
